Science and Research

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

  • Neubauer, A.
  • Wiesmann, T.
  • Vogelmeier, C. F.
  • Mack, E.
  • Skevaki, C.
  • Gaik, C.
  • Keller, C.
  • Figiel, J.
  • Sohlbach, K.
  • Rolfes, C.
  • Renz, H.
  • Wulf, H.
  • Burchert, A.

Keywords

  • Betacoronavirus
  • *Coronavirus Infections
  • Humans
  • Janus Kinase 1
  • *Pandemics
  • *Pneumonia, Viral
  • Pyrazoles
  • *Respiratory Distress Syndrome, Adult
Publication details
DOI: 10.1038/s41375-020-0907-9
Journal: Leukemia
Pages: 2276-2278 
Number: 8
Work Type: Original
Location: UGMLC
Disease Area: PALI, DPLD
Partner / Member: JLU, UMR
Access-Number: 32555296
See publication on PubMed

DZL Engagements

chevron-down